2018
DOI: 10.3389/fnagi.2018.00308
|View full text |Cite
|
Sign up to set email alerts
|

Topographic Markers Drive Proteinopathies to Selection of Target Brain Areas at Onset in Neurodegenerative Dementias

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 39 publications
0
2
0
Order By: Relevance
“…3 ). Interestingly, the regions targeted by degeneration during early stages in AD, considering LOAD, EOAD, FAD and all the syndromic variants together, seem to be arranged at opposite locations along the same A-P, D-V, and M-L brain axes [ 366 ] ( Fig. 3 ).…”
Section: The Scaling Of Molecular Pathology To the Macroscopic Brainmentioning
confidence: 99%
“…3 ). Interestingly, the regions targeted by degeneration during early stages in AD, considering LOAD, EOAD, FAD and all the syndromic variants together, seem to be arranged at opposite locations along the same A-P, D-V, and M-L brain axes [ 366 ] ( Fig. 3 ).…”
Section: The Scaling Of Molecular Pathology To the Macroscopic Brainmentioning
confidence: 99%
“…It is unclear why and from which association cortex tau pathology begins; however, a hypothesis that the genetic programs active during neural development in their target brain area is reactivated as a topographic markers system, which drives proteinopathies, including tau, is proposed. 46 In another hypothesis, phenotypic diversity is interpreted as the Turing reaction, in which two interacting pathogenic proteins (tau and Aβ) spread diffusively through neural networks, including hubs of the default mode network, such as the posterior cingulate, temporo-parietal junctions, hippocampus, and medial prefrontal cortex. 47 Hippocampal sparing Alzheimer's disease and clinical diagnosis of pure Alzheimer's disease with atypical presentation…”
Section: Clinical Diversity On a Common Pathological Substrate In Pure Alzheimer's Diseasementioning
confidence: 99%